Chemocentryx Z Score
CCXI   USA Stock  USD 22.79 0.74 3.36% 
Chemocentryx  Z Score 
Chemocentryx Z Score Analysis
Chemocentryx's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2019  2020  2021  2022 (projected)  
Interest Expense  2.15 M  2.64 M  2.69 M  2.91 M 
Gross Profit  36.13 M  64.89 M  31.92 M  36.96 M 
Z Score  =  Sum Of   5 Factors 
Current Chemocentryx Z Score  2.3 
Most of Chemocentryx's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemocentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Chemocentryx Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Chemocentryx is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Chemocentryx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemocentryx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemocentryx's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
In accordance with the company's disclosures, Chemocentryx has a Z Score of 2.3. This is 65.93% lower than that of the Healthcare sector and 31.14% lower than that of the Biotechnology industry. The z score for all United States stocks is 73.62% higher than that of the company.
Chemocentryx Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemocentryx's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemocentryx could also be used in its relative valuation, which is a method of valuing Chemocentryx by comparing valuation metrics of similar companies.Chemocentryx is currently under evaluation in z score category among related companies.
Chemocentryx Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chemocentryx from analyzing Chemocentryx's financial statements. These drivers represent accounts that assess Chemocentryx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemocentryx's important valuation drivers and their relationship over time.
2017  2018  2019  2020  2021  2022 (projected)  
Net Income Per Employee  270.59 K  (499.55 K)  (676.7 K)  (415.07 K)  (477.33 K)  (515.02 K)  
Revenue Per Employee  1.25 M  564.14 K  440.58 K  486.57 K  437.91 K  425.21 K  
Average Assets  152.54 M  190.61 M  223.14 M  447.82 M  461.82 M  498.28 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  18.28 M  (36.23 M)  (51.7 M)  (49.95 M)  (124.34 M)  (127.61 M)  
Earnings Before Interest Taxes and Depreciation Amortization USD  18.28 M  (36.23 M)  (51.7 M)  (49.95 M)  (124.34 M)  (127.61 M)  
Earnings before Tax  17.86 M  (37.97 M)  (55.49 M)  (55.36 M)  (131.75 M)  (135.22 M)  
Average Equity  50.95 M  22.66 M  69.99 M  317.93 M  323.32 M  348.85 M  
Enterprise Value  272.2 M  541.85 M  2.29 B  4.29 B  2.53 B  1.99 B  
Free Cash Flow  4.16 M  15.6 M  (70.91 M)  (96.55 M)  (94.64 M)  (97.13 M)  
Invested Capital  121.05 M  110.52 M  131.18 M  498.12 M  383.12 M  413.37 M  
Invested Capital Average  87.97 M  98.42 M  135.44 M  323.79 M  400.92 M  432.58 M  
Market Capitalization  290.16 M  551.24 M  2.3 B  4.29 B  2.55 B  2.02 B  
Tangible Asset Value  189.33 M  183.31 M  209.08 M  518.9 M  425.65 M  342.64 M  
Working Capital  146.89 M  116.99 M  115.28 M  390.01 M  206.16 M  188.55 M 
Chemocentryx Institutional Holders
Institutional Holdings refers to the ownership stake in Chemocentryx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemocentryx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in highprofile magazines, and presentations at investor conferences help move the stock higher, increasing Chemocentryx's value.Security Type  Shares  Value  
Fmr Llc  Common Shares  10.6 M  266.5 M  
Vanguard Group Inc  Common Shares  5.1 M  128.3 M  
Blackrock Inc  Common Shares  4.3 M  107.7 M  
State Street Corp  Common Shares  3.6 M  91.3 M  
Pictet Asset Management Sa  Common Shares  1.8 M  46.1 M  
Perceptive Advisors Llc  Common Shares  1.7 M  41.5 M  
Invesco Ltd  Common Shares  1.6 M  40.4 M 
Chemocentryx Fundamentals
Return On Equity  (39.23) %  
Return On Asset  (17.19) %  
Operating Margin  (403.17) %  
Current Valuation  1.12 B  
Shares Outstanding  70.03 M  
Shares Owned by Insiders  11.96 %  
Shares Owned by Institutions  76.20 %  
Number of Shares Shorted  6 M  
Price to Earning  40.53 X  
Price to Book  5.05 X  
Price to Sales  49.53 X  
Revenue  32.22 M  
Gross Profit  (51.07 M)  
EBITDA  (126.78 M)  
Net Income  (131.75 M)  
Cash and Equivalents  264.49 M  
Cash per Share  3.73 X  
Total Debt  73.28 M  
Debt to Equity  0.26 %  
Current Ratio  4.27 X  
Book Value Per Share  4.52 X  
Cash Flow from Operations  (75.62 M)  
Short Ratio  5.13 X  
Earnings Per Share  (1.74) X  
Number of Employees  178  
Beta  1.84  
Market Capitalization  1.6 B  
Total Asset  78.16 M  
Retained Earnings  (441.3 M)  
Working Capital  66.54 M  
Current Asset  72.03 M  
Current Liabilities  5.49 M  
Z Score  2.3 
About Chemocentryx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemocentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemocentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemocentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 178 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Chemocentryx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities 
All Next  Launch Module 
Pair Trading with Chemocentryx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.Chemocentryx Pair Correlation
Correlation Analysis For Direct Indexing and Taxloss Harvesting
The ability to find closely correlated positions to Chemocentryx could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Chemocentryx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemocentryx  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemocentryx to buy it.
The correlation of Chemocentryx is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemocentryx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemocentryx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemocentryx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Continue to Chemocentryx Piotroski F Score and Chemocentryx Valuation analysis. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Chemocentryx Stock analysis
When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing  Go  
Shere PortfolioTrack or share privately all of your investments from the convenience of any device  Go  
ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world  Go  
Fundamental AnalysisView fundamental data based on most recent published financial statements  Go  
Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.  Go 
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.